Literature DB >> 17999917

Involvement of NF-kappaB-mediated maturation of ADAM-17 in the invasion of oral squamous cell carcinoma.

Yasuo Takamune1, Tetsuro Ikebe, Osamu Nagano, Masanori Shinohara.   

Abstract

The involvement of a disintegrin and metalloprotease domain (ADAM)-17 on the cancer invasion was investigated in oral squamous cell carcinoma (OSCC) cells. TNFalpha induced the conversion from the proform of ADAM-17 to its mature form time-dependently. TNFalpha also cleaved CD44 to its small fragments, as observed by a Western blot analysis. The transfection of ADAM-17 siRNA partially suppressed the expression of ADAM-17 as well as the cleavage of CD44. On the other hand, TNFalpha activated a transcription factor NF-kappaB in OSCC cells, while NBD peptide, an NF-kappaB inhibitor, inhibited the ADAM-17 maturation, thus suggesting that NF-kappaB is involved in ADAM-17 maturation. Moreover, an in vitro invasion assay revealed that both ADAM-17 siRNA and NBD peptides strongly suppressed the TNFalpha-induced invasion of OSCC cells through the matrix. In conclusion, ADAM-17 plays an important role in cancer invasion probably through CD44 cleavage.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17999917     DOI: 10.1016/j.bbrc.2007.11.010

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  16 in total

Review 1.  ADAM-17: the enzyme that does it all.

Authors:  Monika Gooz
Journal:  Crit Rev Biochem Mol Biol       Date:  2010-04       Impact factor: 8.250

2.  Suppression of ADAM17-mediated Lyn/Akt pathways induces apoptosis of human leukemia U937 cells: Bungarus multicinctus protease inhibitor-like protein-1 uncovers the cytotoxic mechanism.

Authors:  Wen-Hsin Liu; Long-Sen Chang
Journal:  J Biol Chem       Date:  2010-08-02       Impact factor: 5.157

3.  Dopamine Increases CD14+CD16+ Monocyte Transmigration across the Blood Brain Barrier: Implications for Substance Abuse and HIV Neuropathogenesis.

Authors:  Tina M Calderon; Dionna W Williams; Lillie Lopez; Eliseo A Eugenin; Laura Cheney; Peter J Gaskill; Mike Veenstra; Kathryn Anastos; Susan Morgello; Joan W Berman
Journal:  J Neuroimmune Pharmacol       Date:  2017-01-29       Impact factor: 4.147

4.  Selective inhibition of nuclear factor-κB by nuclear factor-κB essential modulator-binding domain peptide suppresses the metastasis of highly metastatic oral squamous cell carcinoma.

Authors:  Takuya Tanaka; Hideki Nakayama; Yoshihiro Yoshitake; Atsushi Irie; Masashi Nagata; Kenta Kawahara; Yasuo Takamune; Ryoji Yoshida; Yoshihiro Nakagawa; Hidenao Ogi; Satoru Shinriki; Kazutoshi Ota; Akimitsu Hiraki; Tetsuro Ikebe; Yasuharu Nishimura; Masanori Shinohara
Journal:  Cancer Sci       Date:  2012-01-16       Impact factor: 6.716

Review 5.  Tumor necrosis factor-alpha-converting enzyme activities and tumor-associated macrophages in breast cancer.

Authors:  Stephen L Rego; Rachel S Helms; Didier Dréau
Journal:  Immunol Res       Date:  2014-01       Impact factor: 2.829

6.  Prognostic significance of kappaB-Ras1 expression in gliomas.

Authors:  Hong Lin; Yangang Wang; Xiang Zhang; Bolin Liu; Wei Zhang; Jinxiang Cheng
Journal:  Med Oncol       Date:  2011-02-08       Impact factor: 3.064

7.  Platelet IκB kinase-β deficiency increases mouse arterial neointima formation via delayed glycoprotein Ibα shedding.

Authors:  Shujian Wei; Huan Wang; Guoying Zhang; Ying Lu; Xiaofei An; Shumei Ren; Yunmei Wang; Yuguo Chen; James G White; Chunxiang Zhang; Daniel I Simon; Chaodong Wu; Zhenyu Li; Yuqing Huo
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-12-13       Impact factor: 8.311

8.  The ADAMs family of proteases: new biomarkers and therapeutic targets for cancer?

Authors:  Michael J Duffy; Maeve Mullooly; Norma O'Donovan; Sumainizah Sukor; John Crown; Aisling Pierce; Patricia M McGowan
Journal:  Clin Proteomics       Date:  2011-06-09       Impact factor: 3.988

9.  Late repression of NF-κB activity by invasive but not non-invasive meningococcal isolates is required to display apoptosis of epithelial cells.

Authors:  Ala-Eddine Deghmane; Hela El Kafsi; Dario Giorgini; Aziza Abaza; Muhamed-Kheir Taha
Journal:  PLoS Pathog       Date:  2011-12-01       Impact factor: 6.823

10.  Transcription factor Sp1 induces ADAM17 and contributes to tumor cell invasiveness under hypoxia.

Authors:  Alexandra Szalad; Mark Katakowski; Xuguang Zheng; Feng Jiang; Michael Chopp
Journal:  J Exp Clin Cancer Res       Date:  2009-09-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.